Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Spapen

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Critical Care Medicine|October 1, 1995
Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shockH Zhang, P Rogiers, J C Preiser, et al.
Minerva Anestesiologica|August 1, 2014
Measured versus calculated resting energy expenditure in critically ill adult patients. Do mathematics match the gold standard?E De Waele, T Opsomer, P M Honoré, et al.
Shock (Augusta, Ga.)|May 1, 1996
Regional arteriovenous differences in P(CO2) and pH can reflect critical organ oxygen delivery during endotoxemiaH Zhang, P Rogiers, D De Backer, et al.
Acta Anaesthesiologica Scandinavica|October 1, 2008
Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment?K Janssen van Doorn, K J van Doorn, H Spapen, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 7, 2020
MECCIAS trial: Metabolic consequences of continuous veno-venous hemofiltration on indirect calorimetryJ Jonckheer, J Demol, K Lanckmans, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1996
Effects of nitric oxide donor SIN-1 on oxygen availability and regional blood flow during endotoxic shockH Zhang, P Rogiers, G Friedman, et al.
Acta Clinica Belgica|March 26, 2009
90-day follow-up of patients treated with Drotrecogin Alfa (activated) for severe sepsis: a Belgian open label studyJ Decruyenaere, D De Backer, H Spapen, et al.
Acta Clinica Belgica|April 5, 2008
A registry of patients treated with drotrecogin alfa (activated) in Belgian intensive care units--an observational studyJ L Vincent, P F Laterre, J Decruyenaere, et al.
Critical Care Medicine|April 12, 2006
Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trialJean-Louis Vincent, Herbert D M H Spapen, Jacques Creteur, et al.
Acta Anaesthesiologica Scandinavica|June 6, 2015
Measuring resting energy expenditure during extracorporeal membrane oxygenation: preliminary clinical experience with a proposed theoretical modelE De Waele, K van Zwam, S Mattens, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Critical Care Medicine|October 1, 1995
Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shockH Zhang, P Rogiers, J C Preiser, et al.
Minerva Anestesiologica|August 1, 2014
Measured versus calculated resting energy expenditure in critically ill adult patients. Do mathematics match the gold standard?E De Waele, T Opsomer, P M Honoré, et al.
Shock (Augusta, Ga.)|May 1, 1996
Regional arteriovenous differences in P(CO2) and pH can reflect critical organ oxygen delivery during endotoxemiaH Zhang, P Rogiers, D De Backer, et al.
Acta Anaesthesiologica Scandinavica|October 1, 2008
Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment?K Janssen van Doorn, K J van Doorn, H Spapen, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 7, 2020
MECCIAS trial: Metabolic consequences of continuous veno-venous hemofiltration on indirect calorimetryJ Jonckheer, J Demol, K Lanckmans, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1996
Effects of nitric oxide donor SIN-1 on oxygen availability and regional blood flow during endotoxic shockH Zhang, P Rogiers, G Friedman, et al.
Acta Clinica Belgica|March 26, 2009
90-day follow-up of patients treated with Drotrecogin Alfa (activated) for severe sepsis: a Belgian open label studyJ Decruyenaere, D De Backer, H Spapen, et al.
Acta Clinica Belgica|April 5, 2008
A registry of patients treated with drotrecogin alfa (activated) in Belgian intensive care units--an observational studyJ L Vincent, P F Laterre, J Decruyenaere, et al.
Critical Care Medicine|April 12, 2006
Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trialJean-Louis Vincent, Herbert D M H Spapen, Jacques Creteur, et al.
Acta Anaesthesiologica Scandinavica|June 6, 2015
Measuring resting energy expenditure during extracorporeal membrane oxygenation: preliminary clinical experience with a proposed theoretical modelE De Waele, K van Zwam, S Mattens, et al.
Pageof 6